Kadsurenone distinguishes between different platelet activating factor receptor subtypes on macrophages and polymorphonuclear leucocytes

No abstract is available for this paper.

• Publication year

  1986

• Venue

  British Journal of Pharmacology

• Publication date

  1986-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1476-5381.1986.tb10816.xPMID 3006857PMCID PMC1916546
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

  1997cited by this paper
• Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.

  1985cited by this paper
• Biology and biochemistry of platelet-activating factor

  1983cited by this paper
• Platelet activating factor (PAF) induces the oxidative burst in macrophages.

  1983cited by this paper
• Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).

  1981cited by this paper
• Novel effects of 1-O-hexadecyl-2-acyl-sn-glycero-3-phosphorycholine mediators on human leukocyte function: delineation of the specific roles of the acyl substituents.

  1980cited by this paper
• pA2 and receptor differentiation: a statistical analysis of competitive antagonism.

  1979cited by this paper
• IMMUNIZATION OF DISSOCIATED SPLEEN CELL CULTURES FROM NORMAL MICE

  1967cited by this paper

• Of rodents, research and relationships: a pharmacological odyssey

  2024cites this paper
• An Overview of Neolignans of the Genus Piper L.: Isolation Methods and Biological Activities.

  2017cites this paper
• [Function of platelet activating factor in asthma].

  2008cites this paper
• Cardiovascular properties of yangambin, a lignan isolated from Brazilian plants.

  2006cites this paper
• Exogenous platelet-activating factor stimulates cell proliferation in mouse pre-implantation embryos prior to the fourth cell cycle and shows isoform-specific stimulatory effects

  2001cites this paper
• Review: G-protein-coupled receptors on eosinophils.

  2000cites this paper
• Yangambin, a lignan obtained from Ocotea duckei, differentiates putative PAF receptor subtypes in the gastrointestinal tract of rats.

  2000cites this paper
• Heterogeneous platelet-activating factor (PAF) receptors and calcium increase in platelets and macrophages.

  1999cites this paper
• The increase in the steady-state level of major histocompatibility complex mRNA in the host peripheral T lymphocytes due to ischaemia-reperfusion injury.

  1999cites this paper
• Platelet-activating factor plays a role in the mechanism of major histocompatibility complex in T lymphocytes.

  1999cites this paper
• Pharmacology of the eosinophil.

  1999cites this paper
• Inflammatory mediators of asthma: an update.

  1998cites this paper
• Heparin ameliorates pulmonary hypertension induced by platelet-activating factor in pigs.

  1998cites this paper
• Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses.

  1997cites this paper
• Pharmacological evidence for the putative existence of two different subtypes of PAF receptors on platelets and leukocytes; studies with yangambin.

  1997cites this paper
• Role of platelet-activating factor on cardiovascular dysfunction in postischemic shock in pigs.

  1997cites this paper
• Evidence for platelet-activating factor receptor subtypes on human polymorphonuclear leukocyte membranes.

  1997cites this paper
• Lexipafant (BB‐882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis

  1996cites this paper
• Role of platelet-activating factor antagonism in posthemorrhage septic shock in pigs.

  1996cites this paper
• Yangambin: a new naturally-occurring platelet-activating factor receptor antagonist: in vivo pharmacological studies.

  1995cites this paper
• Characterization of eosinophil homotypic aggregation

  1995cites this paper
• Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils.

  1994cites this paper
• 8 – Biological Properties of Platelet-Activating Factor

  1994cites this paper
• 9 – Platelet-Activating Factor: Receptors and Receptor Antagonists

  1994cites this paper
• 3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a novel series of platelet activating factor antagonists.

  1994cites this paper
• Partial agonist effect of the platelet‐activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart

  1993cites this paper
• Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics

  1993cites this paper
• Effect of SR 27417 on the binding of [3H]PAF to rabbit and human platelets and human polymorphonuclear leukocytes.

  1993cites this paper
• Stimulation of human polymorphonuclear leukocytes by leukotriene B4 and platelet‐activating factor: an ultrastructural and pharmacological study

  1993cites this paper
• Possible Existence of Two Subsets of Platelet‐Activating Factor Receptor to Mediate Polyphosphoinositide Breakdown and Calcium Influx in Neuroblastoma × Glioma Hybrid NG 108–15 Cells

  1992cites this paper
• Does airway smooth muscle care about platelet-activating factor?

  1992cites this paper
• Bacterial lipopolysaccharide up-regulates platelet-activating factor-stimulated Ca2+ mobilization and eicosanoid release in human Mono Mac 6 cells.

  1992cites this paper
• Pulmonary vascular reactivity: effect of PAF and PAF antagonists.

  1992cites this paper
• Platelet-activating factor in inflammation and pulmonary disorders.

  1992cites this paper
• Characterization of the antagonist activity of the PAF antagonists RP 59227 and WEB 2086 on elicited guinea pig peritoneal macrophages. Evidence for variable affinities and kinetics.

  1992cites this paper
• Platelet-activating factor-mediated transmembrane signaling in human B lymphocytes is regulated through a pertussis- and cholera toxin-sensitive pathway.

  1992cites this paper
• SRI 63‐675: A Platelet Activating Factor Receptor Antagonist

  1992cites this paper
• Molecular biology. Inflammatory activities.

  1991cites this paper
• Inflammatory activities

  1991cites this paper
• [Paf-acether and digestive tract].

  1991cites this paper
• Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.

  1991cites this paper
• Priming interactions between platelet activating factor and histamine in the in vivo microcirculation

  1991cites this paper
• 1‐O‐hexadecyl‐2‐acetyl‐sn‐glycero‐3‐phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet‐activating factor with partial agonist activity

  1991cites this paper
• Differential actions of platelet‐activating factor (PAF) receptor antagonists on the vasodilator and vasoconstrictor effects of PAF in the rat perfused heart

  1991cites this paper
• Structure-activity relationships for platelet-activating factor (PAF) and analogues reveal differences between PAF receptors on platelets and macrophages.

  1991cites this paper
• Influence of plasma protein content and platelet number on the potency of PAF and its antagonist RP 59227 in rabbit platelet preparations

  1990cites this paper
• Platelet-activating factor-induced aggregation of rat alveolar macrophages.

  1990cites this paper
• Pharmacologic Characterization of the Rabbit Neutrophil Receptor for Platelet-Activating Factor

  1990cites this paper
• 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.

  1990cites this paper
• 1,25-(OH)2 vitamin D-3 enhances Paf-stimulated calcium mobilization in U937 cells by expression of specific Paf binding sites.

  1990cites this paper
• Distinct stimulatory effect of platelet-activating factor on prostaglandin I2 and thromboxane A2 biosynthesis by rat dental pulp.

  1990cites this paper
• Platelet activating factor does not release histamine from human dispersed cutaneous mast cells

  1990cites this paper
• Identification and pharmacological characterization of functional platelet-activating factor receptors on human B lymphoblastic cell lines /

  1990cites this paper
• Antagonists of platelet-activating factor: chemistry, pharmacology and clinical applications.

  1990cites this paper
• Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms.

  1990cites this paper
• Interaction ofthePafantagonist WEB 2086andits hetrazepine analogues withhumanplatelets and endothelial cells

  1989cites this paper
• Characterization of platelet-activating factor binding sites on uterine membranes from pregnant rabbits.

  1989cites this paper
• Hetrazepines as antagonists of platelet activating factor

  1989cites this paper
• Antagonism of platelet activating factor‐induced chemiluminescence in guinea‐pig peritoneal macrophages in differing states of activation

  1989cites this paper
• Equine peritoneal macrophage production of thromboxane and prostacyclin in response to platelet activating factor and its receptor antagonist SRI 63-441.

  1989cites this paper
• Comparison between Paf-Acether Receptors on Intact Washed Human Platelets and Human Endothelial Cells in Culture

  1989cites this paper
• CV 6209 IS A NON‐COMPETITIVE ANTAGONIST OF PLATELET‐ACTIVATING FACTOR RECEPTORS ON GUINEA‐PIG RESIDENT PERITONEAL MACROPHAGES

  1989cites this paper
• Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig.

  1989cites this paper
• Evidence against a role for platelet-activating factor in hypoxic pulmonary vasoconstriction in the rat.

  1989cites this paper
• Effects of platelet-activating factor on ion transport in isolated rat jejunum.

  1989cites this paper
• The role of platelet activating factor in allergic inflammation.

  1989cites this paper
• Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells

  1989cites this paper
• Octylonium bromide, an antagonist of platelet-activating factor.

  1989cites this paper
• Evidence for two platelet activating factor receptors on eosinophils: dissociation between PAF-induced intracellular calcium mobilization degranulation and superoxides anion generation in eosinophils.

  1989cites this paper
• The metabolism of glycerophospholipid and its regulation in monocytes and macrophages.

  1989cites this paper
• Effects of PAF and PAF antagonists on the shape of venous endothelial cellsin vitro

  1989cites this paper
• Comparison of three paf-acether receptor antagonist ginkgolides.

  1988cites this paper
• Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea‐pig and platelet aggregation in man

  1988cites this paper
• Characterization of receptors for platelet‐activating factor on platelets, polymorphonuclear leukocytes and macrophages

  1988cites this paper
• Effects of REV 5901, a 5‐lipoxygenase inhibitor and leukotriene antagonist, on pulmonary responses to platelet activating factor in the guinea‐pig

  1988cites this paper
• PA2 values for antagonists of platelet activating factor on aggregation of rabbit platelets

  1988cites this paper
• Platelet-activating factor as a mediator of allergic disease.

  1988cites this paper
• Hydrolysis of platelet activating factor and its methylated analogs by acetylhydrolases.

  1988cites this paper
• Inflammatory mediators and asthma.

  1988cites this paper
• Natural antagonists of platelet‐activating factor

  1988cites this paper
• Antagonism of the platelet activating factor‐induced rise of the intracellular calcium ion concentration of U937 cells

  1988cites this paper
• Effects of the PAF-antagonist CV-3988 on PAF-induced changes in mucus secretion and in respiratory and circulatory variables in ferrets.

  1987cites this paper
• Changes in glutathione peroxidase activities and the oxidative burst of leukocytes during inflammation in the mouse and rat.

  1987cites this paper
• CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.

  1987cites this paper
• Extracellular and Intracellular Activities of PAF

  1987cites this paper
• Interaction of Paf-Acether with the Human Platelet: Receptor Binding and Pharmacology

  1987cites this paper
• Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes.

  1987cites this paper
• A Role For Platelet Activating Factor In Shock And Acute Lung Injury

  1987cites this paper
• Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro.

  1987cites this paper
• Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats.

  1987cites this paper
• Evidence for a Role for Na+‐H+ Exchange in Activation of Human Platelets by PAF

  1987cites this paper
• Effect of the PAF-antagonist SRI 63-441 on the allergic reaction in awake dogs with natural asthma.

  1987cites this paper
• Species difference in the specific receptors of platelet activating factor.

  1986cites this paper
• Pharmacological analysis of guinea-pig macrophage chemiluminescence responses to platelet activating factor and opsonized zymosan.

  1986cites this paper
• Conformationally restricted analogs of platelet-activating factor (PAF)

  1986cites this paper
• Molecular design toward biologically significant compounds based on platelet activating factor: a highly selective agonist as a potential antihypertensive agent.

  1986cites this paper